Related Experiment Video
Updated: Jun 22, 2026

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts
Published on: November 5, 2012
Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair
Ali Pedram1, Mahnaz Razandi, Albert J Evinger
1Department of Medicine, University of California, Irvine, Irvine CA 92717, USA.
Abstract:
DNA damage activates the ataxia telangiectasia-mutated and Rad3-related (ATR) kinase signal cascade. How this system is restrained is not understood. We find that in estrogen receptor (ER)-positive breast cancer cells, UV or ionizing radiation and hydroxyurea rapidly activate ATR-dependent phosphorylation of endogenous p53 and Chk1. 17-beta-estradiol (E(2)) substantially blocks ATR activity via plasma membrane-localized ERalpha. E(2)/ER reduces the enhanced association of ATR andTopBP1 proteins that follows DNA damage and strongly correlates to ATR activity. E(2) inhibits ATR activation through rapid PI3K/AKT signaling: AKT phosphorylates TopBP1 at Serine 1159, thereby preventing the enhanced association of ATR with TopBP1 after DNA damage. E(2) also inhibits Claspin:Chk1 protein association via AKT phosphorylation of Chk1, preventing Chk1 signaling to the G2/M checkpoint. ATR-phosphorylation of p53 induces p21 transcription, prevented by E(2)/ER. E(2) delays the assembly and prolongs the resolution of gammaH2AX and Rad51 nuclear foci and delays DNA repair. E(2)/ER also increases the chromosomal damage seen from cell exposure to IR. Therefore, the restraint of ATR cascade activation may be a novel estrogen action relevant to breast cancer.
Insights
Estrogen restrains DNA damage response by blocking ATR kinase activation in ER-positive breast cancer cells. This estrogen action may be relevant to breast cancer development and treatment.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- DNA damage activates the ataxia telangiectasia-mutated and Rad3-related (ATR) kinase signaling cascade.
- The mechanisms restraining ATR activity, particularly in the context of breast cancer, are not fully understood.
Purpose of the Study:
- To investigate how estrogen receptor (ER) signaling influences ATR activation in response to DNA damage in ER-positive breast cancer cells.
- To elucidate the molecular pathways by which estrogen restrains ATR activity and its downstream effects on DNA repair and genomic stability.
Main Methods:
- Treatment of ER-positive breast cancer cells with DNA-damaging agents (UV, ionizing radiation, hydroxyurea) and 17-beta-estradiol (E(2)).
- Assessment of ATR kinase activity, phosphorylation of p53 and Chk1, and protein-protein interactions (ATR-TopBP1, Claspin-Chk1).
- Analysis of cell cycle progression, DNA repair foci (gammaH2AX, Rad51), and chromosomal damage.
Main Results:
- 17-beta-estradiol (E(2)) substantially blocks ATR activation via plasma membrane-localized ERalpha, reducing ATR-dependent phosphorylation of p53 and Chk1.
- E(2)/ER reduces ATR-TopBP1 association and inhibits Claspin-Chk1 association through PI3K/AKT signaling, preventing G2/M checkpoint activation.
- E(2) delays DNA repair, prolongs the resolution of DNA damage markers, and increases chromosomal damage, indicating impaired DNA repair.
Conclusions:
- Estrogen receptor signaling restrains ATR cascade activation in ER-positive breast cancer cells.
- This estrogen-mediated restraint of ATR activity impacts DNA repair dynamics and genomic stability.
- The inhibition of ATR signaling by estrogen may represent a novel mechanism relevant to breast cancer progression and therapeutic strategies.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

